Gilead Sciences Inc - Company & Market Research Reports

Home /
Companies /
Gilead Sciences Inc

Founded in 1987 Gilead Sciences is a biopharmaceutical company focused on developing innovative treatments for life threatening illnesses. Their areas of research include HIV/AIDs, Liver Diseases, Hematology, Oncology, Cardiovascular and Respiratory disease. Gilead Sciences is based in California, USA and their product portfolio consists of well-known treatments like Atripla, Sovaldi, Zydelig, Viread and many more.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 162
Infectious Diseases Drugs 123
Genomics 101
Liver and Kidney Disorders Drugs 68
Immune Disorders Drugs 61
Pharmaceuticals 51
Drug Discovery 48
Cardiovascular Drugs 44
Biopharmaceuticals 42
Biotechnology 41
Leukemia Drugs 37
HIV/AIDS Drugs 37
Lymphoma Drugs 29
Allergy and Immunology 28
Clinical Trials 28
Musculoskeletal Disorders Drugs 27
Enzymes 26
Respiratory Drugs 25
Oncology 22
Pulmonary Medicine 20
Central Nervous System Drugs 20
Drug Delivery 19
Infusions and Injectables 17
Pharmaceutical Manufacturing 17
Gastrointestinal Drugs 13
Infectious Disease Testing 12
Vaccines 12
Endocrine and Metabolic Disorders Drugs 12
Healthcare Services 10
Diagnostics 10
Hematological Drugs 10
Sexual and Reproductive Health Drugs 10
Hematology 9
Antibiotics 9
Pharmaceutical Intermediates 8
Therapeutic Area 8
Optical Disorders Drugs 8
Breast Cancer Drugs 8
Stem Cells 8
Drugs by Therapeutic Area 6
Women's Health 6
Lung Cancer Drugs 6
Company Reports 5
Hepatology 5
Colon Cancer Drugs 5
Analgesics 5
Nanomedicine 5
Cervical Cancer Drugs 4
Anesthetic Drugs 4
Biomarkers 4
Dermatology 4
Skin Cancer Drugs 4
Dermatological Drugs 4
Immunosuppressive Drugs 4
Addiction Disorders Drugs 3
Liver Cancer Drugs 3
Generic Drugs 3
Bladder Cancer Drugs 3
Dental 3
Optical 3
Medical Devices 3
Needles and Syringes 3
Over the Counter (OTC) Drugs 3
Mental Disorders Drugs 3
Biosimilars and Biosuperiors 3
E-Healthcare 2
Pharmacoeconomics 2
Prostate Cancer Drugs 2
Ovarian Cancer Drugs 2
Brain Cancer Drugs 2
In Vitro Diagnostics 2
Cancer Vaccines 2
Kidney Cancer Drugs 2
Vitamins and Dietary Supplements 2
Laboratory Equipment 2
Pediatrics 2
Gastroenterology 2
Cardiology 2
Urological Disorders Drugs 2
Animal Pharmaceuticals 1
Neurology 1
Urology and Nephrology 1
Fertility Services 1
Proteomics 1
Cardiovascular Devices 1
Home Testing and Home Healthcare 1
Healthcare 1
Managed Care 1
Transdermal and Transmucosal Drug Delivery 1
Inhalers and Nebulisers 1
Blood Banking 1
Hospital Management 1
Surgical Procedures 1
Pancreatic Cancer Drugs 1
Thyroid Cancer Drugs 1
Uterine Cancer Drugs 1
Anatomy 1
Endocrinology 1
Alzheimer's Disease Drugs 1
Asthma Drugs 1
Bronchitis Drugs 1
Schizophrenia Drugs 1
Psoriasis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



284 reviews

1,020 Results (Page 39 of 51)
- Relevance
  Sort by

a4ß7 Integrin Antagonists Market - Global Forecast 2026-2032

 Report
January 2026
187 Pages
Global

From

€3168EUR$3,545USD£2,710GBP

€3520EUR$3,939USD£3,011GBP

Protein Inhibitors Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4012EUR$4,490USD£3,433GBP

Antifungal Drugs: Technologies and Global Markets 2021-2026

 Report
November 2021
295 Pages
Global

From

€4915EUR$5,500USD£4,205GBP

Exocrine Pancreatic Insufficiency Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4012EUR$4,490USD£3,433GBP

Acromegaly Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4012EUR$4,490USD£3,433GBP

NEED HELP FINDING THE RIGHT PRODUCT? Brian will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Regulatory T-Cell Therapies Market by Target Indications, Key Players and Key Geographies: Industry Trends and Global Forecast, 2021-2035

 Report
October 2021
145 Pages
Global

From

€4289EUR$4,799USD£3,669GBP

Prescription Drugs Market - Forecasts from 2025 to 2030

 Report
December 2024
155 Pages
Global

From

€3530EUR$3,950USD£3,020GBP

Crohn's Disease - Pipeline Insight, 2025

 Clinical Trials
April 2025
240 Pages
Global

From

€2681EUR$3,000USD£2,293GBP

U.S. Gene Therapy Market - Industry Outlook & Forecast 2022-2027

 Report
March 2022
208 Pages
United States

From

€3128EUR$3,500USD£2,676GBP

Ataxia Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4012EUR$4,490USD£3,433GBP

Drug Discovery Technologies Market - Global Forecast 2026-2032

 Report
August 2026
183 Pages
Global

From

€3168EUR$3,545USD£2,710GBP

€3520EUR$3,939USD£3,011GBP

Cancer Immunotherapy - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

 Report
July 2026
130 Pages
Global

From

€4245EUR$4,750USD£3,631GBP

Lymphoma Therapeutics Market Size, Share & Industry Trends Analysis Report By Treatment Type, By Disease Type, By Route of Administration (Injectable, and Oral Route), By Distribution Channel, By Regional Outlook and Forecast, 2023-2029

 Report
April 2023
260 Pages
Global

From

€3217EUR$3,600USD£2,752GBP

Atrial Fibrillation - Pipeline Insight, 2025

 Clinical Trials
July 2025
60 Pages
Global

From

€1340EUR$1,500USD£1,147GBP

Toll-like Receptor 9 (TLR-9) Modulator - Pipeline Insight, 2025

 Clinical Trials
April 2025
100 Pages
Global

From

€1787EUR$2,000USD£1,529GBP

Drug Discovery Services Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4012EUR$4,490USD£3,433GBP

Headache Disorders Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4012EUR$4,490USD£3,433GBP

US Cell & Gene Therapy Market - Focused Insights 2023-2028

 Report
May 2023
United States

From

€1340EUR$1,500USD£1,147GBP

Telemedicine - Market Insight, Competitive Landscape, and Market Forecast - 2030

 Report
July 2024
150 Pages
Global

From

€3351EUR$3,750USD£2,867GBP

Cancer Biological Therapy Market - Global Forecast 2026-2032

 Report
August 2026
198 Pages
Global

From

€3168EUR$3,545USD£2,710GBP

€3520EUR$3,939USD£3,011GBP

1,020 Results (Page 39 of 51)
- 1
- 37
- 38
- 39
- 40
- 41

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.